OCU410

· Ocugen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OCU410, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy [Phase 1, Phase 2]